305 related articles for article (PubMed ID: 7083199)
41. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
MacIndoe JH; Woods GR; Etre LA; Covey DF
Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
[TBL] [Abstract][Full Text] [Related]
42. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
43. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
[TBL] [Abstract][Full Text] [Related]
44. Medical adrenalectomy and plasma steroids in advanced breast carcinoma.
Newsome HH; Brown PW; Terz JJ; Lawrence W
Surgery; 1978 Jan; 83(1):83-9. PubMed ID: 619476
[TBL] [Abstract][Full Text] [Related]
45. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Harris AL; Dowsett M; Smith IE; Jeffcoate SL
Br J Cancer; 1983 May; 47(5):621-7. PubMed ID: 6221746
[TBL] [Abstract][Full Text] [Related]
46. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Rose DP; Davis TE
Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
[TBL] [Abstract][Full Text] [Related]
47. The hormonal activity of the postmenopausal ovary.
Vermeulen A
J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
[TBL] [Abstract][Full Text] [Related]
48. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
49. Relationship between urine and plasma estrogen ratios.
Longcope C; Pratt JH
Cancer Res; 1978 Nov; 38(11 Pt 2):4025-8. PubMed ID: 698950
[TBL] [Abstract][Full Text] [Related]
50. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
Goss PE; Powles TJ; Dowsett M; Hutchison G; Brodie AM; Gazet JC; Coombes RC
Cancer Res; 1986 Sep; 46(9):4823-6. PubMed ID: 2942241
[TBL] [Abstract][Full Text] [Related]
51. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
52. Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.
van Veelen H; Willemse PH; Sleijfer DT; Sluiter WJ; Doorenbos H
Cancer Treat Rep; 1985 Sep; 69(9):977-83. PubMed ID: 3161613
[TBL] [Abstract][Full Text] [Related]
53. Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma.
Santen RJ; Worgul TJ; Lipton A; Harvey H; Boucher A; Samojlik E; Wells SA
Ann Intern Med; 1982 Jan; 96(1):94-101. PubMed ID: 7053713
[TBL] [Abstract][Full Text] [Related]
54. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
55. Significance of aromatase activity in human breast cancer.
Miller WR; Hawkins RA; Forrest AP
Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
[TBL] [Abstract][Full Text] [Related]
56. Relationship of obesity to blood estrogens.
Zumoff B
Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
[TBL] [Abstract][Full Text] [Related]
57. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Van Deijk WA; Blijham GH; Mellink WA; Meulenberg PM
Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
[TBL] [Abstract][Full Text] [Related]
58. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
Prost O; Turrel MO; Dahan N; Craveur C; Adessi GL
Cancer Res; 1984 Feb; 44(2):661-4. PubMed ID: 6581863
[TBL] [Abstract][Full Text] [Related]
59. Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
Bird CE; Masters V; Sterns EE; Clark AF
Cancer Res; 1982 Nov; 42(11):4797-800. PubMed ID: 6290048
[TBL] [Abstract][Full Text] [Related]
60. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
